Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleDrug Discovery and Translational Medicine

Targeting KCa1.1 channels with a scorpion venom peptide for the therapy of rat models of rheumatoid arthritis

Mark R. Tanner, Michael W. Pennington, Brayden H. Chamberlain, Redwan Huq, Elizabeth J. Gehrmann, Teresina Laragione, Percio S. Gulko and Christine Beeton
Journal of Pharmacology and Experimental Therapeutics February 16, 2018, jpet.117.245118; DOI: https://doi.org/10.1124/jpet.117.245118
Mark R. Tanner
1 Baylor College of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mark R. Tanner
Michael W. Pennington
2 Peptides International;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael W. Pennington
Brayden H. Chamberlain
1 Baylor College of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Redwan Huq
1 Baylor College of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Redwan Huq
Elizabeth J. Gehrmann
1 Baylor College of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teresina Laragione
3 Icahn School of Medicine at Mount Sinai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Percio S. Gulko
3 Icahn School of Medicine at Mount Sinai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine Beeton
1 Baylor College of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christine Beeton
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

jpet.117.245118
DOI 
https://doi.org/10.1124/jpet.117.245118
PubMed 
29453198

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online February 16, 2018.

Article Versions

  • You are currently viewing an Earlier version of this article (February 16, 2018 - 10:10).
  • View the most recent version of this article
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Mark R. Tanner1,
  2. Michael W. Pennington2,
  3. Brayden H. Chamberlain1,
  4. Redwan Huq1,
  5. Elizabeth J. Gehrmann1,
  6. Teresina Laragione3,
  7. Percio S. Gulko3, and
  8. Christine Beeton1,*
  1. 1 Baylor College of Medicine;
  2. 2 Peptides International;
  3. 3 Icahn School of Medicine at Mount Sinai
  1. ↵*Address correspondence to: beeton{at}bcm.edu

Statistics from Altmetric.com

Article usage

Article usage: February 2018 to March 2023

AbstractFullPdf
Feb 20188790175
Mar 201885313221
Apr 20184836961
May 20182572047
Jun 20181501415
Jul 20181021012
Aug 201883815
Sep 201894911
Oct 20181321114
Nov 201897512
Dec 201853610
Jan 2019871123
Feb 20196979
Mar 2019761437
Apr 2019225033
May 2019154015
Jun 2019142810
Jul 2019163629
Aug 2019122612
Sep 2019383721
Oct 2019446530
Nov 2019143019
Dec 201948496
Jan 202035387
Feb 2020313425
Mar 202075697
Apr 2020657811
May 2020788317
Jun 2020741007
Jul 202067816
Aug 2020806710
Sep 2020691039
Oct 2020652744
Nov 20208437414
Dec 20201134266
Jan 202111311810
Feb 202196689
Mar 20211157616
Apr 2021967912
May 202112311117
Jun 2021106779
Jul 20211167913
Aug 2021117677
Sep 20211066921
Oct 20211106722
Nov 20211026526
Dec 20211016110
Jan 20221318730
Feb 2022837511
Mar 2022836521
Apr 2022876235
May 20221247624
Jun 2022937717
Jul 202291712
Aug 202270565
Sep 2022766717
Oct 202282487
Nov 2022836312
Dec 2022854612
Jan 202387606
Feb 202380424
Mar 202390468

Next
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 385 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 385, Issue 1
1 Apr 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Targeting KCa1.1 channels with a scorpion venom peptide for the therapy of rat models of rheumatoid arthritis
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleDrug Discovery and Translational Medicine

Targeting KCa1.1 channels with a scorpion venom peptide for the therapy of rat models of rheumatoid arthritis

Mark R. Tanner, Michael W. Pennington, Brayden H. Chamberlain, Redwan Huq, Elizabeth J. Gehrmann, Teresina Laragione, Percio S. Gulko and Christine Beeton
Journal of Pharmacology and Experimental Therapeutics February 16, 2018, jpet.117.245118; DOI: https://doi.org/10.1124/jpet.117.245118

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleDrug Discovery and Translational Medicine

Targeting KCa1.1 channels with a scorpion venom peptide for the therapy of rat models of rheumatoid arthritis

Mark R. Tanner, Michael W. Pennington, Brayden H. Chamberlain, Redwan Huq, Elizabeth J. Gehrmann, Teresina Laragione, Percio S. Gulko and Christine Beeton
Journal of Pharmacology and Experimental Therapeutics February 16, 2018, jpet.117.245118; DOI: https://doi.org/10.1124/jpet.117.245118
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • TAK-994: an orally available orexin 2 receptor agonist
  • XEN602 Inhibits DMT1 in vitro and in vivo
  • Metformin alters lipidome independent of diabetes control
Show more Drug Discovery and Translational Medicine

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics